Featured Research

from universities, journals, and other organizations

Guidance molecules: New therapy shows novel therapeutic approach to fighting inflammation

Date:
April 9, 2011
Source:
Charité - Universitätsmedizin Berlin
Summary:
Researchers in Germany have succeeded in finding a new therapeutic approach to certain inflammatory reactions of the body. The approach focuses on guidance molecules, which reduce the body's own immune system to the required level and prevent excessive and damaging inflammation. Possible applications include therapies for inflammation, such as blood poisoning, but also in chronic inflammation and immunological inflammations such as rheumatoid arthritis and organ rejection.

Researchers at Charité – Universitätsmedizin Berlin have succeeded in finding a new therapeutic approach to certain inflammatory reactions of the body. The new approach, developed under the leadership of Prof. Dr. Schwab, focuses on guidance molecules, which reduce the body's own immune system to the required level and prevent excessive and damaging inflammation. Possible applications include therapies for inflammation, such as blood poisoning, but also in chronic inflammation and immunological inflammations such as rheumatoid arthritis and organ rejection.

Two types of guidance molecules, the attractive and the repulsive, direct the growth of nerve cells to the actual target. The designation of these molecules ("guidance" molecules) also describes the exclusive function that was previously attributed to them, namely to show the growing nerve fibers the way. The fundamentally new approach to the research of Prof. Dr. Schwab and his team at the Berlin-Brandenburg Center for Regenerative Therapies (BCRT) is the realization that these guidance molecules have an additional hitherto unknown role in the immune system.

The problem with the so-called "excessive" inflammation of the body is that the immune system overreacts and there by aggravates the actual inflammation.  Here the repulsive molecules drive the immune molecules (leukocytes) into the way and thus prevent the inflammation from getting out of control or becoming chronic. The research is published in the current issue of the journal Proceedings of the National Academy of Sciences.

The new approach represents a softer, more specific alternative to the orthodox approaches to the combat of inflammation such as cortisone, due to cortisone’s non-specific effect as well as many associated side effects which pose problems for many patients. Prof. Dr. Schwab is optimistic that through this research, a new effective therapy could be found, which can be effective in the fight against excessive inflammation; due to their fundamentally new understanding of this important aspect of the immune system.


Story Source:

The above story is based on materials provided by Charité - Universitätsmedizin Berlin. Note: Materials may be edited for content and length.


Journal Reference:

  1. V. Mirakaj, S. Brown, S. Laucher, C. Steinl, G. Klein, D. Kohler, T. Skutella, C. Meisel, B. Brommer, P. Rosenberger, J. M. Schwab. Repulsive guidance molecule-A (RGM-A) inhibits leukocyte migration and mitigates inflammation. Proceedings of the National Academy of Sciences, 2011; DOI: 10.1073/pnas.1015605108

Cite This Page:

Charité - Universitätsmedizin Berlin. "Guidance molecules: New therapy shows novel therapeutic approach to fighting inflammation." ScienceDaily. ScienceDaily, 9 April 2011. <www.sciencedaily.com/releases/2011/04/110407093234.htm>.
Charité - Universitätsmedizin Berlin. (2011, April 9). Guidance molecules: New therapy shows novel therapeutic approach to fighting inflammation. ScienceDaily. Retrieved August 20, 2014 from www.sciencedaily.com/releases/2011/04/110407093234.htm
Charité - Universitätsmedizin Berlin. "Guidance molecules: New therapy shows novel therapeutic approach to fighting inflammation." ScienceDaily. www.sciencedaily.com/releases/2011/04/110407093234.htm (accessed August 20, 2014).

Share This




More Health & Medicine News

Wednesday, August 20, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Ebola-Hit Sierra Leone's Freetown a City on Edge

Ebola-Hit Sierra Leone's Freetown a City on Edge

AFP (Aug. 19, 2014) — Residents of Sierra Leone's capital voice their fears as the Ebola virus sweeps through west Africa. Duration: 00:56 Video provided by AFP
Powered by NewsLook.com
101-Year-Old Working Man Has All The Advice You Need

101-Year-Old Working Man Has All The Advice You Need

Newsy (Aug. 19, 2014) — Herman Goldman has worked at the same lighting store for almost 75 years. Find out his secrets to a happy, productive life. Video provided by Newsy
Powered by NewsLook.com
Researcher Testing on-Field Concussion Scanners

Researcher Testing on-Field Concussion Scanners

AP (Aug. 19, 2014) — Four Texas high school football programs are trying out an experimental system designed to diagnose concussions on the field. The technology is in response to growing concern over head trauma in America's most watched sport. (Aug. 19) Video provided by AP
Powered by NewsLook.com
American Ebola Patient Apparently Improving, Outbreak Is Not

American Ebola Patient Apparently Improving, Outbreak Is Not

Newsy (Aug. 19, 2014) — Nancy Writebol, an American missionary who contracted Ebola, is apparently getting better, according to her husband. The outbreak, however, is not. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins